|
|
| IPO Open | Apr 30, 2018 |
| IPO Close | May 3, 2018 |
| IPO Price | ₹51 |
| Face Value | ₹10 |
| IPO Size | ₹7.29 Cr |
| Listing At | BSE SME |
| Lot Size | 2000 |
Jul 18, 2022 3:29:00 AM
Biotech IPOs haven't received warm welcomes of late and Pacific Biosciences is in an increasingly crowded DNA sequencing field. Plus, this market wants proven companies and Pacific Biosciences is ...
Publish by : TheStreet.comAug 8, 2022 5:30:00 AM
The Indonesia stock market has finished higher in five straight sessions, rising more than 130 points or 2 percent along the way. The Jakarta Composite Index now sits just above the 7,080-point ...
Publish by : NasdaqAug 9, 2022 5:30:00 AM
The Indonesia stock market has moved higher in six straight sessions, rising more than 130 points or 2 percent along the way. The Jakarta Composite Index now sits just above the 7,085-point plateau ...
Publish by : NasdaqJul 29, 2021 11:54:00 AM
Windlas Biotech, the domestic pharmaceutical formulations ... via offer for sale. To Know All IPO Related News, Click Here The total fund raising would be Rs 401.53 crore at upper end of price ...
Publish by : MSNJul 25, 2022 6:08:00 PM
Ginkgo Bioworks acquired biotechnology firm Zymergen ... Ginkgo’s stock has similarly flailed since its September 2021 IPO, falling 71.8% since.
Publish by : ForbesJul 7, 2022 12:34:00 PM
Rossari Biotech: The stock of the speciality chemical maker listed at Rs 670 on the BSE, a premium of 57.65 per cent compared to the issue price of Rs 425 a share.
Publish by : NDTVJul 21, 2022 3:03:00 PM
If you look at the IPOs of ... look at biotech and digital health, and then world preservation, so climate and sustainability. The diversity of the team is really important to us, but we also ...
Publish by : Business InsiderJul 20, 2022 6:12:00 PM
MGAM stock is wildly risky, so prospective IPO participants must engage carefully ... event in the 2018 Asian Games held in Jakarta, Indonesia, signifying how quickly paradigms have shifted.
Publish by : Benzinga.comJul 11, 2022 7:12:00 PM
New York, July 11, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Biotechnology Services Global Market Opportunities And Strategies To 2031" - https://www ...
Publish by : Benzinga.comJul 19, 2022 12:47:00 PM
The pandemic shone a spotlight on the pharmaceutical and biotech industry and their share prices hit new highs as a result. Big pharmaceutical players have continued to perform well into 2022 even ...
Publish by : MSNJul 21, 2022 6:34:00 PM
Jul 21, 2022 (The Expresswire) -- [118 Report Pages] "Chromatography in Biotechnology Market" Insights 2022 By Types (Gas Chromatography, Thin Layer Chromatography, Supercritical Fluid ...
Publish by : MarketWatchJun 24, 2022 6:37:00 AM
Jun 24, 2022 (AmericaNewsHour) -- Research Nester published a report titled "Pharmaceutical & Biotechnology Environmental ... South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand ...
Publish by : MarketWatchThe IPO Shares of Indo US Bio-Tech Limited IPO are proposed to list on Friday, May 11, 2018 at BSE SME. The public issue of Indo US BioTech IPO was opened on Apr 30, 2018 and closed for subscription on May 3, 2018. Indo US BioTech IPO Listing Date and Information:
The allotment status of Indo US Bio-Tech Limited IPO is now available online. The public issue of Indo US BioTech IPO was open on Apr 30, 2018 and closed for subscription on May 3, 2018. The equity shares of the company to be list at BSE SME.
The issue of Indo US Bio-Tech Limited opens on Apr 30, 2018 and closes for subscription on May 3, 2018. The equity shares of the company to be list at BSE SME. The price for the issue has been set at Rs 51 Per Equity Share.
Indo US Bio-Tech Limited is entering in the capital market with an IPO of 1,430,000 Equity Shares of Rs 10 aggregating up to Rs 72.93 Crore. The price for the issue has been set at Rs 51 Per Equity Share.
Incorporated in 2004, Gujarat based Indo US Bio-Tech Limited is engaged in the business of breeding products, processing and marketing of high performing open-pollinated and hybrid agricultural seed varieties & (seed testing, soil & water testing ). The company has its own laboratory for seed testing at Junagadh.
The issue opens on Apr 30, 2018 and closes for subscription on May 4, 2018. The equity shares of the company to be list at BSE SME.
The Indo US BioTech IPO is proposed to open on Apr 30, 2018. The IPO application ends on May 3, 2018.
Retail investors can apply in the retail or non-institutional investor category from Apr 30, 2018 to May 3, 2018. The Indo US BioTech IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).
The Indo US BioTech IPO will open for subscription on Apr 30, 2018. The public issue will close on May 3, 2018.
Useful Articles
30 days brokerage free trading
Free - Relationship Manager
Free - Classroom Training
